Modulation of glycolytic ATP production

Details Modulation of glycolytic ATP production Modulation of glycolytic ATP production

1995-06-07

1998-01-13

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 45, 514694, A61K 3170, A61K 31115

Patent

active

057079714

ABSTRACT:
Delivery of fuel and cofactors augments ATP production in cells, and mitigates damages in ischemic or metabolically impaired tissues. The processes may be particularly effective in acute or chronic ischemic conditions, for reversing anesthesia, for treating diabetes, for producing or preventing coma due to lack of fuel or ATP, for reversing processes of aging, as dietary supplements, as performance enhancers, for example, in sports, for tissue transplantation and other surgery, and for cold storage or cryopreservation of tissues such as organs.

REFERENCES:
patent: 4546095 (1985-10-01), Markov
patent: 4703040 (1987-10-01), Markov
patent: 4757052 (1988-07-01), Markov
patent: 5039665 (1991-08-01), Markov
patent: 5395822 (1995-03-01), Izumi et al.
The Merck Index, 12th Edition,Merck & Co., Inc., Whitehouse Station, NJ., Nos. 2531, 4491 and 6429, pp. 417, 418, 763 and 1088, 1966.

Affiliated with

Also associated with

Rating

Modulation of glycolytic ATP production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of glycolytic ATP production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of glycolytic ATP production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-326284